BSE filing, NSE: NEPHROPLUS. Summary written from the filing by ALFA Finder's alert engine.
Nephrocare Health Services Ltd: key numbers
- Share price
- ₹614.55
- Market cap
- ₹6,166 Cr
- Revenue (annual)
- ₹998.8 Cr
- Net profit (annual)
- ₹76.84 Cr
- P/E (TTM)
- 72.5×Sector 52.8×
- Promoter holding
- 58.31%-5.54% QoQ
- FII holding
- 11.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephrocare Health Services Ltd
All →Nephrocare Health Services Acquisition
Nephrocare's Philippines subsidiary agreed to acquire dialysis center assets from JCM Summit Health under an Asset Transfer Agreement. Consideration is undisclosed but the deal exceeds materiality thresholds.
Nephrocare Health Services Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Nephrocare Health Services Board Meeting Date
Nephrocare Health Services intimated that its Board is scheduled for 3 Nov 2026 to consider Q2/H1 FY27 results. The trading window remains closed from 1 Oct to 5 Nov 2026.
Nephrocare Health Services Capital Structure Change
Polar Capital Funds PLC acquired 2,549,478 shares (2.535%) in Nephrocare Health Services Ltd through an off-market placing. This acquisition increases their total stake to 8.311%.
Nephrocare Health Services Credit Rating
India Ratings upgraded Nephrocare Health Services' long-term bank loan facilities to IND AA-/Stable. The agency also affirmed the company's short-term credit ratings.
Nephrocare Health Services Merger & Restructuring
Nephrocare Health Services Ltd announced the rationalisation and consolidation of its step-down subsidiaries in the Philippines. This internal reorganization streamlines the group's existing structure.
Other employee stock options announcements
All →Studds Accessories Employee Stock Options
Studds Accessories granted 1,30,000 ESOPs to eligible employees under its 2026 scheme at an exercise price of Rs 334.90. Options vest over time, converting to equity shares on exercise.
Poonawalla Fincorp Employee Stock Options
Poonawalla Fincorp allotted 30,773 equity shares under its employee stock option schemes on 31 October 2026. The shares rank pari passu with existing equity.
Eveready Industries India Employee Stock Options
Eveready Industries granted 48,000 stock options to eligible employees under its ESOP 2026 plan, approved by the NRC on 31 October 2026. The filing is an employee stock option grant intimation with no cash consideration stated.
Max Estates Employee Stock Options
Max Estates allotted 632 equity shares to an option holder under its ESOP Plan 2023. The allotment raises paid-up capital; no transaction price is stated.
Zen Technologies Employee Stock Options
Zen Technologies granted 12,000 ESOPs at ₹500 each under its 2021 scheme. Options vest after one year and are exercisable within two years thereafter.
KFIN Technologies Employee Stock Options
KFin Technologies allotted 37,163 equity shares on exercise of ESOP options under its 2020 plan. Paid-up capital rises to Rs 1,72,90,92,420.